|
[technology
opportunities: LIFE SCIENCES]
> Anesthetic-Eluting Polymethylmethacrylate (PMMA)
Researchers at Queen’s University have developed anesthetic-eluting PMMA for applications in localized pain management.
> Bioinformatics
and Data Mining: software and algorithms
GeneLinker™ gene espression analysis software
offers a powerful set of analysis and visualization
tools for the exploration of gene expression data. Proprietary
algorithms such as SLAM (SubLinear Association Mining)
and IBIS (Integrated Bayesian Inference System) provide
an efficient way to charcterize higher-order correlations
among objects in a multidimensional dataset.
>
Biodegradable Elastomer
A patented method of formulating resorbable, drug-eluting elastomers from clinically accepted monomers, such as D,L-lactide and ε-caprolactone.
>
Canine Factor VIII Gene, Protein and Use
Technology providing methods useful during diagnosis
of a canine Factor VIII deficiency-dependent bleeding
disorder, and methods for treating a canine afflicted
with such a disorder.
>
DETECTS
- Software for Identifying Circulatory Emboli
Researchers
at Queen’s University have developed DETECTS --
Detection of Emboli using
Trans-esophageal Echocardiography for Counting, Total
volume, and Size estimation. This software tool accurately
measures flow rates of emboli in the ascending aorta
while simultaneously providing quantitative data on
size, volume and count.
> Hydrogel – Calcium Phosphate Linking Technology
A novel method of covalently
binding hydrogels to calcium phosphate-based surfaces, thus, enabling the production of MACI-based
osteochondral implants for use in cartilage repair.
>
HyperSpace™
Helmet for Detecting Eye Movement
Apparatus for diagnosing a neurological disorder in
a subject by detecting the subject's eye movement, allowing
children with ADHD to be diagnosed and medication optimized.
>
Kinarm™
- Mechanical Linkage to Study Multi-Joint Movements
Robotic exoskeleton that can both sense and modify the
mechanics of multi-joint movements. Researchers can
use this device to examine a range of questions on motor
coordination and learning. Development of a clinical
assessment tool is underway.
>
Mammalian
Sperm Proteins
Protein identified at Queen's that may play a critical
role in the activation of the oocyte, with possible applications
in human fertilization and contraception methods.
>
Methods
of Treating a CNS Disorder Using N,N-Dichlorinated Amino
Acids and Derivatives
Compounds and methods for the synthesis of chlorinated
amino acids for treatment of central nervous system
(CNS) disorders including epilepsy and Alzheimer's.
>
Monoclonal
Antibodies to Baculovirus Proteins
Suite of
monoclonal antibodies directed to baculovirus proteins,
produced in mouse hybridoma cell lines, isolated and
characterized.
>
Multi-Drug
Resistant Protein (MRP) Technology
Queen's University researchers Drs. Susan Cole
and Roger Deeley were the first to clone the human Multi-drug
Resistance Protein (MRP) following their 1992 discovery
of the gene encoding for Multidrug Resistance Proteins
(MRP).
> NO-Chimera
Drugs & NO-Mimetic Therapeutic Approaches to Neurological
Disorders including Alzheimer’s Disease
A large proprietary
library of novel nitrates and NO-chimera drugs have
been developed and are extensively protected by patents
that cover novel composition and methods of preparation
and use including in neurological disorders.
> Optical 3-D Exophthalmometer
A cost-effective,
non-contact, non-ionizing exophthalmometer that uses
novel image-based rendering algorithms to construct a 3D computer model of the anterior
surface of the eye and the surrounding soft tissue of the face.
>
Porphyrin
Derivatives for Cancer Treatment
New class of porphyrin derivatives having both chemotherapeutic
and photosensitizing activity.
>
Protease
Mediated Drug Delivery
Method of delivering cytotoxic drugs in high concentrations
to maximize the amount of the cytotoxic agent taken
up by malignant cells while minimizing toxicity to surrounding
normal tissue.
>
Proteoglycan Antagonists
A novel method
for producing homogenous cyclodextran derivatives which
have been showed to inhibit nerve process growth (neurite
growth) are available for license.
>
Recombinant r-Lp(a)
A novel method for producing recombinant lipoprotein
A of specific sizes for research and clinical applications,
including the development of diagnostic kits is available
for license.
> Surface Guided Total Knee System
A fixed-bearing total knee system that
employs an innovative bearing surface design to guide the motion of the joint in both flexion
and extension and to attain normal kinematics in deep knee bending without the use of an
intercondylar cam/post.
|